146 related articles for article (PubMed ID: 33175638)
1. Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study.
Hill E; Nemec M; Marlow L; Sherman SM; Waller J
J Med Screen; 2021 Sep; 28(3):333-340. PubMed ID: 33175638
[TBL] [Abstract][Full Text] [Related]
2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
3. Women's acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results.
Smith LW; Racey CS; Gondara L; Krajden M; Lee M; Martin RE; Stuart G; Peacock S; Coldman AJ; Franco EL; van Niekerk D; Ogilvie GS
BMJ Open; 2021 Oct; 11(10):e052084. PubMed ID: 34620663
[TBL] [Abstract][Full Text] [Related]
4. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of extending HPV-based cervical screening intervals from 3 to 5 years: an interview study with women in England.
Nemec M; Waller J; Barnes J; Marlow LAV
BMJ Open; 2022 May; 12(5):e058635. PubMed ID: 35508345
[TBL] [Abstract][Full Text] [Related]
6. Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.
McBride E; Marlow L; Forster AS; Moss S; Myles J; Kitchener H; Patnick J; Waller J
BMJ Open; 2016 Dec; 6(12):e014356. PubMed ID: 28011816
[TBL] [Abstract][Full Text] [Related]
7. Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening.
Tatar O; Wade K; McBride E; Thompson E; Head KJ; Perez S; Shapiro GK; Waller J; Zimet G; Rosberger Z
J Womens Health (Larchmt); 2020 Mar; 29(3):390-405. PubMed ID: 31479381
[No Abstract] [Full Text] [Related]
8. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon.
Sossauer G; Zbinden M; Tebeu PM; Fosso GK; Untiet S; Vassilakos P; Petignat P
PLoS One; 2014; 9(10):e109788. PubMed ID: 25333793
[TBL] [Abstract][Full Text] [Related]
9. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
10. Testing key messages about extending cervical screening intervals.
A V Marlow L; Nemec M; Barnes J; Waller J
Patient Educ Couns; 2022 Aug; 105(8):2757-2762. PubMed ID: 35440375
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis.
Tatar O; Thompson E; Naz A; Perez S; Shapiro GK; Wade K; Zimet G; Gilca V; Janda M; Kahn J; Daley E; Rosberger Z
Prev Med; 2018 Nov; 116():40-50. PubMed ID: 30172799
[TBL] [Abstract][Full Text] [Related]
13. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.
Leinonen MK; Nieminen P; Lönnberg S; Malila N; Hakama M; Pokhrel A; Laurila P; Tarkkanen J; Anttila A
BMJ; 2012 Nov; 345():e7789. PubMed ID: 23197596
[TBL] [Abstract][Full Text] [Related]
14. Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening.
Rohner E; McGuire FH; Liu Y; Li Q; Miele K; Desai SA; Schmitt JW; Knittel A; Nelson JAE; Edelman C; Sivaraman V; Baker A; Romocki LS; Rahangdale L; Smith JS
J Womens Health (Larchmt); 2020 Jul; 29(7):971-979. PubMed ID: 32212991
[No Abstract] [Full Text] [Related]
15. Increasing the perceived relevance of cervical screening in older women who do not plan to attend screening.
Marlow LAV; Ryan M; Waller J
Sex Transm Infect; 2020 Feb; 96(1):20-25. PubMed ID: 31395750
[TBL] [Abstract][Full Text] [Related]
16. Information needs among women taking part in primary HPV screening in England: a content analysis.
Marlow L; Forster AS; McBride E; Rockliffe L; Kitchener H; Waller J
BMJ Open; 2020 Dec; 10(12):e044630. PubMed ID: 33323451
[TBL] [Abstract][Full Text] [Related]
17. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
Smith LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS
BMC Public Health; 2014 Oct; 14():1060. PubMed ID: 25303975
[TBL] [Abstract][Full Text] [Related]
18. Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
Gibson-Helm M; Slater T; MacDonald EJ; Stevenson K; Adcock A; Geller S; Parag V; Lambert C; Bennett M; Hibma M; Sykes P; Saville M; Hawkes D; Stanton JA; Clueard MA; Jelley G; Lawton B
PLoS One; 2023; 18(3):e0280643. PubMed ID: 36952546
[TBL] [Abstract][Full Text] [Related]
19. Awareness and Beliefs About Cervical Cancer, the HPV Vaccine, and Cervical Cancer Screening Among Ghanaian Women with Diverse Education Levels.
Williams MS; Kenu E; Adanu A; Yalley RA; Lawoe NK; Dotse AS; Adu RF; Fontaine K
J Cancer Educ; 2019 Oct; 34(5):897-903. PubMed ID: 29974412
[TBL] [Abstract][Full Text] [Related]
20. Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening.
Chatzistamatiou K; Vrekoussis T; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moschaki V; Ntoula M; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Daponte A; Vanakara P; Paschopoulos M; Stefos T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Deligeoroglou E; Panoskaltsis T; Adonakis G; Michail G; Stamatopoulos K; Agorastos T
J Womens Health (Larchmt); 2020 Nov; 29(11):1447-1456. PubMed ID: 32757997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
